Is long-term use of GLP-1 weight-loss drugs safe?

Sincity Press Staff 1 hour ago 4 min read 1
⚡ Sincity Press Brief

It is estimated that around 11 percent of U.S. adults are taking GLP-1 medications for weight loss.

By Niamh Ordner The Dallas Morning News

September 25, 2026 - 6:00 am

GLP-1s look to beryllium rapidly becoming the “wonder drug” of the 21st century.

In the past fewer years, these drugs person permeated quality feeds, societal media and adjacent day-to-day conversations. It is present estimated that astir 11 percent of U.S. adults are taking GLP-1 medications for value loss, with immoderate adjacent turning to “gray market” versions of the drugs due to the fact that of accessibility and fiscal issues.

While these drugs aren’t new, their surge successful popularity is. And with overmuch inactive chartless astir the effects of semipermanent GLP-1 use, it raises the question: Could these alleged wonderment drugs beryllium excessively bully to beryllium true?

What are GLP-1s?

GLP-1s, oregon glucagonlike peptide-1s, are synthesized versions of a hormone that helps power humor sugars and, erstwhile you’re eating, lets you cognize erstwhile you are full, said Dr. Jaime Almandoz, a prof of interior medicine and the aesculapian manager of the Weight Wellness Program astatine the University of Texas Southwestern Medical Center successful Dallas.

“Essentially, they marque america satisfied with little nutrient for longer,” Almandoz said, making GLP-1s a revolutionary attraction for Type 2 diabetes and for helping with chronic value management.

The archetypal GLP-1 cause was approved by the Food and Drug Administration arsenic a Type 2 diabetes attraction successful 2005, and the archetypal GLP-1 cause for value nonaccomplishment was approved 9 years later.

Many ample objective trials amusement robust benefits beyond value loss, Almandoz said. The 2023 SELECT study, helium noted, reported a 20 percent mean simplification successful the hazard of bosom attacks, strokes and different large cardiovascular events among obese participants portion taking the GLP-1 semaglutide.

Some probe suggests GLP-1s could supply alleviation from substance-use disorders oregon cravings, said Sarah Messiah, the subordinate dean for probe and manager of the Child and Adolescent Population Health Program astatine UT Southwestern.

“GLP-1s look to person a wide effect connected reward processes successful general,” Messiah said. “It’s not circumstantial to food. People are besides anecdotally seeing changes successful the mode it’s making them respond to different substances, similar alcohol.”

What don’t we know

“I bash deliberation it is due to ask, what are we going to larn with overmuch longer-term use? And however bash we marque definite these medications are being utilized appropriately?” Almandoz said.

Some probe has been conducted connected the semipermanent effectiveness and information of GLP-1 usage. Studies published betwixt 2018 and 2025 showed sustained value nonaccomplishment and humor sweetener power implicit 40- to 120-week periods, but immoderate participants did acquisition gastrointestinal broadside effects specified arsenic nausea, vomiting and diarrhea.

“If you don’t request it, you astir apt won’t get the aforesaid benefits, and you mightiness beryllium putting yourself astatine hazard for imaginable broadside effects,” Messiah said. The broadside effects aren’t constricted to gastrointestinal issues and tin see pancreatitis, acute kidney wounded and thyroid cancer.

Additional concerns

Other large points of concern, Almandoz said, are proviso shortages, security issues and precocious out-of-pocket costs that tin restrict entree to GLP-1s for those who would payment the astir from them. A survey conducted by Cleveland Clinic past twelvemonth recovered astir fractional of patients who discontinued usage of GLP-1s did truthful due to the fact that of fiscal reasons. According to the University of Chicago Medicine, GLP-1s tin outgo astir $700 to $800 per month.

This tin origin patients to crook to cheaper “gray market” alternatives, Messiah said, referring to risky, off-market drugs not approved by the Food and Drug Administration. These nonprescription drugs mightiness look charismatic to radical who don’t needfully person aesculapian needs for GLP-1s.

It’s important to spot a healthcare nonrecreational who is well-versed connected GLP-1s earlier starting them, Almandoz said, truthful they tin measurement the risks and benefits and counsel whether GLP-1 usage is appropriate.

GLP-1s shouldn’t beryllium treated arsenic a metallic bullet, either. Almandoz emphasized the value of utilizing the drugs arsenic a co-therapy, pointing toward making manner changes successful fare and workout to guarantee affirmative wellness outcomes.

“We request to marque definite we are focusing connected wellness outcomes,” Almandoz said, “and not conscionable trying to get the lowest fig connected the standard possible.”